Galenica AG
GALE
Rangering i aksjer
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
Aksjekurs
$108.43
Markedsverdi
$5.40B
Endring (1 dag)
1.19%
Endring (1 år)
-3.89%
Land
CH
Handel Galenica AG (GALE)
Kategori
Healthcare
P/E-forhold for Galenica AG (GALE)
P/E-forhold per October 2026 TTM: 27.85
Ifølge Galenica AG sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 27.85. Ved slutten av 2024 hadde selskapet en P/E på 20.26.
P/E-forholdshistorikk for Galenica AG fra 2013 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 27.85 | 3.50% |
| 2025 | 26.91 | 32.87% |
| 2024 | 20.26 | -3.04% |
| 2023 | 20.89 | -8.19% |
| 2022 | 22.75 | 12.28% |
| 2021 | 20.26 | 19.69% |
| 2020 | 16.93 | -28.24% |
| 2019 | 23.59 | 64.85% |
| 2018 | 14.31 | -30.64% |
| 2017 | 20.63 | -19.97% |
| 2016 | 25.78 | -2.72% |
| 2015 | 26.50 | 0.87% |
| 2014 | 26.28 | 0.00% |
| 2013 | 0.00 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 26.02 | -6.58% |
US
|
|
| 25.18 | -9.60% |
US
|
|
| 35.41 | 27.15% |
US
|
|
| 13.31 | -52.21% |
US
|
|
| 45.62 | 63.78% |
AU
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.